| Home | Article Database | Fun Stuff | Resources | Tools & Calculators | Search HY
Ask the Mental Health Expert Archives 2001-2004
Expert Home | Archives by Date | Search Expert Archives | For Professionals | For Consumers
Abilify
Q.
I work with autistic children. Recently a parent asked if I knew of a new medication on the market called "Abilify". Because it is relatively new, I can't find any information on it. Could you please tell me what the drug does and what the side effects are? Where can I locate information on it?
A.
This new antipsychotic medication's generic
name is aripiprazole. Aripiprazole has a unique receptor binding profile
that combines partial agonist activity at D2 (dopamine-2) and 5HT1A
(serotonin) receptors, with potent antagonism at 5HT2A receptors.
Clinical
studies in acute schizophrenic relapse, chronic schizophrenia and acute
mania show it is sinificantly more effective than placebo. Once-daily
aripiprazole 15-30 mg is as effective as haloperidol 10 mg/day and
risperidone 6 mg/day in short-term treatment of schizophrenia and more
effective than haloperidol 7-10 mg/day in maintenance of response in chronic
schizophrenia.
Aripiprazole appears to be well tolerated, with most studies
suggesting a frequency of adverse effects similar to placebo. (This may
change as clinical experience is gained in real-world patients, rather
than research subjects). Unlike many of the other atypical antipsychotics,
aripiprazole seems not to cause significant extrapyramidal side effects,
prolactin elevation, excessive weight gain, problems with blood sugar, or
cardiac rhythm disturbances. For a review of this promising agent, see DM
Taylor, Int J Clin Pract. 2003 Jan-Feb;57(1):49-54.
Other Resources:
August 2003
Disclaimer Back to Ask the Expert
|